NewslettersImmune Regulation NewsBCG-Induced Tumor Immunity Requires Tumor-Intrinsic CIITA Independent of MHC-IIBy lbeveridge - August 31, 2022084Researchers demonstrated that the IFNγ-driven, tumor cell intrinsic expression of the class II transactivator CIITA was required for activation of a tumor-specific CD4 T-cell response and BCG-induced tumor immunity.[Cancer Immunology Immunotherapy]Abstract